Funding-Quanterix provided the kits for this study free of charge. 37 Conflict of interest–Pons
S, Oriol G, Brengel-Pesce K, Mouton W, Compagnon C are Biomérieux® 38 employeers. …

A reliable diagnostic assay is crucial to early detect new COVID-19 cases and limit severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Since the onset of the …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged since
December, 2019, and spread worldwide, causing the COVID-19 pandemic. Despite COVID-19 …

The activity of sialic acids, known to play critical roles in biology and many pathological
processes, is finely regulated by a class of enzymes called sialidases, also known as …

[3] Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of
103 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25. 104 …

Background The association between SARS-CoV-2 commercial serological assays and
virus neutralization test (VNT) has been poorly explored in mild patients with COVID-19. …

Background The person-to-person transmission of influenza-like illness (ILI) and influenza
has been described mostly in long-term care units. Studies in acute hospital settings are rare …

Background Many commercial assays, of different designs, detecting SARS-CoV-2-specific
antibodies exist but with little experience with them. Objectives The aim of this study was to …

With the availability of vaccines, commercial assays detecting anti-severe acute respiratory
syndrome coronavirus-2 antibodies (Ab) evolved toward quantitative assays directed to the …

BACKGROUND: Neuraminidase inhibitors (NAIs) have been used since 2005 in France.
OBJECTIVE: Influenza viruses isolated in hospital and community cases in winter 2005–2006 …